SCHEMBL19782873

SCHEMBL19782873

FC(F)(F)c1cc(NC(=S)Nc2nc(-c3ccccn3)cs2)ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.55
ADORA3 P0DMS8 5/20 0.53
NPY5R Q15761 1/20 0.52
LMNA P02545 4/20 0.48
MAPT P10636 4/20 0.48
HTT P42858 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
ALOX15 P16050 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 4/20 0.47
HSP90AA1 P07900 1/20 0.47
GAA P10253 1/20 0.47
KDM4A O75164 1/20 0.47
KDM4B O94953 1/20 0.47
KDM5B Q9UGL1 1/20 0.47
NR4A1 P22736 1/20 0.47
VCP P55072 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19782722 0.88 ADORA3 (0.64) GRM4ADORA3NPY5RLMNAMAPT
SCHEMBL7178922 0.78 GRM4 (0.86) GRM4LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL8562560 0.75 BRAF (0.64) GRM4LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL4555026 0.75 LMNA (0.75) GRM4LMNAMAPTHTTSMN1; SMN2
2-Picolinic Acid SCHEMBL7860597 0.72 GRM4 (0.67) GRM4LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL4555072 0.71 LMNA (0.69) GRM4LMNAMAPTHTTSMN1; SMN2
SCHEMBL8561660 0.71 LMNA (0.45) GRM4LMNAMAPTKDM4EALDH1A1
2-Picolinic Acid SCHEMBL7860593 0.71 GRM4 (0.65) GRM4LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL3607683 0.70 MEN1 (0.66) LMNAMAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL4555515 0.70 LMNA (0.68) GRM4LMNAMAPTHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913734-B2 Substituted aminothiazoles BARUCH S. BLUMBERG INSTITUTE 2021-02-09 US disclosed
US-10913734-B2 Substituted aminothiazoles BARUCH S. BLUMBERG INSTITUTE 2021-02-09 US disclosed
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE 2019-08-08 US disclosed
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE 2019-08-08 US disclosed
WO-2018013508-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10913734-B2 Substituted aminothiazoles ABAT, AADAT, BCAT1 GRM4 3089/4885ADORA3 3568/4885NPY5R 3814/4885
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES ABAT, AADAT, BCAT1 GRM4 3089/4885ADORA3 3568/4885NPY5R 3814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.